American Journal of Obstetrics & Gynecology
Volume 200, Issue 5 , Pages 484.e1-484.e5 , May 2009

Metaanalysis vs large clinical trials: which should guide our management?

  • Christina M. Scifres, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO
    • ,
  • Jay D. Iams, MD

      Affiliations

    • Department of Obstetrics and Gynecology, The Ohio State University, Columbus, OH
    • ,
  • Mark Klebanoff, MD, MPH

      Affiliations

    • Division of Epidemiology, Statistics and Prevention Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
    • ,
  • George A. Macones, MD, MSCE

      Affiliations

    • Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO

Received 10 May 2008 ,Revised 10 August 2008 ,Accepted 26 September 2008.

References 

  1. Redman CW, Sargent IL. Latest advances in understanding pre-eclampsia. Science. 2005;308:1592–1594
  2. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of pre-eclampsia. N Engl J Med. 2004;350:672–683
  3. Bussolino F, Benedetto C, Massobrio M, Camussi G. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet. 1980;2:702
  4. Masotti G, Galanti G, Poggesi L, et al. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet. 1979;2:1213–1217
  5. Belizan JM, Villar J. The relationship between calcium intake and edema, proteinuria, and hypertension-gestosis: a hypothesis. Am J Clin Nutr. 1980;33:2202–2210
  6. Belizan JM, Villar J, Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence. Am J Obstet Gynecol. 1988;1598:898–902
  7. Kincaid-Smith P, North RA, Fairly KF, et al. Prevention of pre-eclampsia in women with renal disease: a prospective randomized trial of heparin and dipyridamole. Nephrology. 1995;1:297–300
  8. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343:619–629
  9. Niromanesh S, Laghii S, Mosavi-Jarrahi A. Supplementary calcium in prevention of pre-eclampsia. Int J Obstet Gynecol. 2001;74:17–21
  10. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006;194:639–649
  11. Sibai BM, Caritis SN, Thom E, et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med. 1993;329:1213–1218
  12. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent pre-eclampsia in women at high risk. N Engl J Med. 1998;338:701–705
  13. Golding J. A randomized trial of low dose aspirin for primiparae in pregnancy. BJOG. 1998;105:293–299
  14. Rotchell YE, Cruickshank JK, Phillips Gay M, et al. Barbados low dose aspiring study in pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications. BJOG. 1998;105:286–292
  15. Askey LM, Duley L, Henderson-Smart DJ, Stewart LA PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1791–1798
  16. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for prevention of pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;CD004659
  17. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent pre-eclampsia. N Engl J Med. 1997;337:69–76
  18. Hofmeyer GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2006;CD001059
  19. Easterbrook PS, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867–872
  20. In:  Higgins JPT,  Green S editor. Cochrane handbook for systematic reviews of interventions, version 5.0.0 (updated February 2008): the Cochrane collaboration. 2008;Available at: www.cochrane-handbook.org. Accessed Aug. 1, 2008.
  21. Stewart LA, Clard MJ Cochrane working group on meta-analysis using individual patient data. Practical methodology of meta-analysis using updated individual patient data. Stat Med. 1995;14:2057–2079
  22. Simmonds MC, Higgins JP, Stewart LA, et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trial. 2005;2:209–217
  23. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical estimates of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412
  24. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Lancet. 1999;354:1896–1900
  25. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med. 1997;337:536–542

 This research was supported in part by the Intramural Research Program of the National Institute of Child Health and Human Development, National Institutes of Health.

 Authorship and contribution to the manuscript is limited to the 4 authors indicated. There was no outside funding or technical assistance with the production of this article.

 Cite this article as: Scifres CM, Iams JD, Klebanoff M, Macones GA. Metaanalysis vs large clinical trials: which should guide our management? Am J Obstet Gynecol 2009;200:484.e1-484.e5.

 Reprints not available from the authors.

PII: S0002-9378(08)01098-3

doi: 10.1016/j.ajog.2008.09.873

American Journal of Obstetrics & Gynecology
Volume 200, Issue 5 , Pages 484.e1-484.e5 , May 2009

Article Tools

* Image Usage & Resolution